Possible role of erythropoietin in the pathogenesis of chronic cor pulmonale [4]

Nephrology Dialysis Transplantation

Volumn 20, Issue 12, 2005, Pages 2866-2867

  Allegra, Alessandro ^a   Giacobbe, Maria Stella ^a   Corvaia, Ermanno ^a   Cinquegrani, Maurizio ^a   Corvaja, Elio ^a   Giorgianni, Giovanna ^a   Buemi, Michele ^a  

^a UNIVERSITY OF MESSINA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT ERYTHROPOIETIN;

ADULT; AGED; ANALYSIS OF VARIANCE; ARTERY CATHETER; CARDIOPULMONARY HEMODYNAMICS; CLINICAL ARTICLE; CONTROLLED STUDY; COR PULMONALE; DATA ANALYSIS; HUMAN; LETTER; LUNG ARTERY PRESSURE; LUNG VASCULAR RESISTANCE; MALE; MEAN ARTERIAL PRESSURE; PATHOGENESIS; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; SWAN GANZ CATHETER; SYSTEMIC VASCULAR RESISTANCE;

AGED; ANIMALS; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; ERYTHROPOIETIN, RECOMBINANT; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MICE; MICE, TRANSGENIC; PULMONARY CIRCULATION; PULMONARY HEART DISEASE; PULMONARY WEDGE PRESSURE;

EID: 27944477335     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfi098     Document Type: Letter

References (10)

1. Farber HW, Loscalzo J. Pulmonary arterial hypertension. N Engl J Med 2004; 351: 1655-1665
2. Durmowicz AG, Stenmark KR. Mechanisms of structural remodeling in chronic pulmonary hypertension. Pediatr Rev 1999; 20: E91-e102
3. Allegra A, Galasso A, Siracusano L et al. Administration of recombinant erythropoietin determines increase of peripheral resistances in patients with hypovolemic shock. Nephron 1996; 74: 431-432
4. Creutiziz A, Caspary L, Nonnast-Daniel B. Skin microcirculation and regional peripheral resistance in patients with chronic renal anaemia treated with recombinant human erythropoietin. Eur J Clin Invest 1990; 2: 219-223
5. Buemi M, Allegra A, Lagana A et al. Is erythropoietin-induced hypertension a phenomenon due to the intracellular Ca++ mobilisation? Int Angiol 1994; 13: 75-77
6. Buemi M, Allegra A, Squadrito F. Effects of intravenous administration of rHuEPO in rats with haemorrhagic shock. Nephron 1993; 65: 440-443
7. Calapai G, Marciano MC, Corica F et al. Erythropoietin protects against brain ischemic injury by inibition of nitric oxide formation. Eur J Pharmacol 2000; 401: 349-356
8. Bahlmann FH, De Groot K, Spandau JM et al. Erythropoietin regulates endothelial progenitor cells. Blood 2003; 2: 18
9. Briest W, Homagk L, Baba HA et al. Cardiac remodelling in erythropoietin-transgenic mice. Cell Physiol Biochem 2004; 14: 277-284
10. Foster DJ, Moe OW, Hsia CC. Upregulation of erythropoietin receptor during postnatal and postpneumonectomy lung growth. Am J Physiol Lung Cell Mol Physiol 2004; 287: 1107-1115